High mobility group box-1 (HMGB1) is an endogenous danger signal or alarmin that mediates activation of the innate immune response including chemotaxis and pro-inflammatory cytokine release. HMGB1 has been implicated in the pathophysiology of several neuroinflammatory conditions including ischemia, traumatic brain injury, seizure and chronic ethanol use. In the present review, the unique structural and functional properties of HMGB1 will be explored including its affinity for multiple pattern recognition receptors (TLR2/TLR4), redox sensitivity and adjuvant-like properties. In light of recent evidence suggesting that HMGB1 may also mediate stress-induced sensitization of neuroinflammatory responses, mechanisms of HMGB1 action in neuroinflammatory priming are explored. A model of neuroinflammatory priming is developed wherein glucocorticoids induce synthesis and release of HMGB1 from microglia, which signals through TLR2/TLR4, thereby priming the NLRP3 inflammasome. We propose that if GCs reach a critical threshold as during a fight/flight response, they may thus function as an alarmin by inducing HMGB1, thereby preparing an organism's innate immune system (NLRP3 inflammasome priming) for subsequent immune challenges such as injury, trauma or infection, which are more likely to occur during a fight/flight response. In doing so, GCs may confer a significant survival advantage by enhancing the central innate immune and sickness response to immune challenges.
Introduction
First proposed by Matzinger in 1994, the danger model of immunogenicity postulated that the immune system generates a response to an exogenous or endogenous immunogenic stimulus only if that stimulus induces cellular damage or distress and the consequent release of danger signals (Matzinger, 1994) . That is, the danger model proposes that the salient immunological feature of a stimulus is not its ''foreignness'' (self/non-self model of immunogenicity), but rather its capacity to induce tissue stress or destruction (see review by Pradeau and Cooper comparing the danger model and self/non-self models (Pradeu and Cooper, 2012) ). Thus, the immune system will respond to a stimulus only if that stimulus results in the release of endogenous danger-associated molecular patterns (DAMPs), also known as alarmins, which signal cellular damage and activate the innate immune system (Bianchi, 2007) . The explanatory power of the danger model is particularly relevant to pathophysiological conditions involving sterile injury or trauma. Under such conditions, an inflammatory event is induced in the absence of infection or exposure to pathogenassociated molecular patterns (PAMPs) such as lipopolysaccharide (LPS), which are considered exogenous DAMPs.
Inflammation in the absence of stimulation by PAMPs is not restricted to the periphery. Neuroinflammation and the behavioral sequelae of neuroinflammation (sickness behavior) can be induced under sterile conditions within the CNS such as ischemia, seizure or even psychological stress. Moreover, exposure to exogenous PAMPs such as LPS in the periphery induces neuroinflammatory processes without entering the CNS. Clearly then, peripheral immune-to-brain signaling pathways can initiate neuroinflammation after peripheral exposure to exogenous PAMPs. These pathways have been well characterized (Maier and Watkins, 2003) , but the proximate mediator(s) released within the CNS that directly signals innate immune cells (e.g. microglia) to induce a pro-inflammatory response whether in the context of an exogenous PAMP (e.g. peripheral LPS exposure) or endogenous (sterile injury) immunological threat remains unknown. Although the danger model was developed to help understand peripheral innate immunity, extension to the CNS raises the intriguing possibility that DAMPs released within the brain in response to exogenous or endogenous immunogenic stimuli may play a pivotal role as
